BioHealth News Archive

UK Biotech Companies Thriving in Maryland and Philadelphia Hubs · BioBuzz

UK Biotech Companies Thriving in Maryland and Philadelphia Hubs · BioBuzz

For decades, the United States and the United Kingdom have enjoyed a special relationship that crosses political, economic, and military lines. But, the two…

Read More
Announcing the Maryland Future 20 | Maryland Business News

Announcing the Maryland Future 20 | Maryland Business News

Following a statewide search to identify Maryland’s most innovative start-up companies with the potential to be the state’s next major business success story, Governor…

Read More
OS Therapies Acquires All Indications for OST-HER2 (Listeria monocytogenes) in Solid Tumors, Including Canines

OS Therapies Acquires All Indications for OST-HER2 (Listeria monocytogenes) in Solid Tumors, Including Canines

CAMBRIDGE, Md., Nov. 17, 2020 /PRNewswire/ -- OS Therapies, a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat and cure Osteosarcoma (OS)…

Read More
What monoclonal antibodies are – and why we need them as well as a vaccine

What monoclonal antibodies are – and why we need them as well as a vaccine

When President Trump was diagnosed with COVID-19, one of the cutting-edge experimental therapies he received was a mixture of monoclonal antibodies. But now a…

Read More

Maryland Today | UMD Ranked in Top 10 for Innovation and Entrepreneurship Education for Sixth Straight Year

For the sixth consecutive year, the University of Maryland (UMD) earned a top 10 ranking in The Princeton Review’s annual survey of top schools…

Read More
SR One Completes Spin-out from GSK and Closes First Fund at $500 Million | Business | thedailytimes.com

SR One Completes Spin-out from GSK and Closes First Fund at $500 Million | Business | thedailytimes.com

SR One, a trans-Atlantic biotech venture capital firm, announced today the close of its first independent fund, having recently completed its spinout from GlaxoSmithKline…

Read More
The state of AI in 2020 | McKinsey

The state of AI in 2020 | McKinsey

The results of this year’s McKinsey Global Survey on artificial intelligence (AI) suggest that organizations are using AI as a tool for generating value.…

Read More
Protecting Our Future: Spurring Innovation to Support Pediatric Preparedness

Protecting Our Future: Spurring Innovation to Support Pediatric Preparedness

With COVID-19, we’ve seen our preparedness response tested, and the question remains, how can we be better prepared to protect some of the most…

Read More
BLUE KNIGHT™ Symposium

BLUE KNIGHT™ Symposium

In seeking to combat emerging infectious diseases and other 21st century health threats, the path to better prepared, protected, and healthy individuals, families, and…

Read More
Join the Force: An Info Session on JLABS @ Washington, DC and the BLUE KNIGHT™ Collaboration

Join the Force: An Info Session on JLABS @ Washington, DC and the BLUE KNIGHT™ Collaboration

BLUE KNIGHT™, a collaboration between Johnson & Johnson Innovation – JLABS and the Biomedical Advanced Research and Development Authority (BARDA), offers emerging life science…

Read More
Private S. Korean investments in biohealth to reach 10 trillion won by 2023 – EconoTimes

Private S. Korean investments in biohealth to reach 10 trillion won by 2023 – EconoTimes

South Korea’s leading biologics companies will invest hundreds of billions of won to building additional plants that would push the total amount of private…

Read More
Immunomic Therapeutics and CoImmune Therapeutics Enter into Partnership to Manufacture ITI-1020, a Novel Experimental Cell Therapy for Glioblastoma | Business Wire

Immunomic Therapeutics and CoImmune Therapeutics Enter into Partnership to Manufacture ITI-1020, a Novel Experimental Cell Therapy for Glioblastoma | Business Wire

ROCKVILLE, Md. & DURHAM, N.C.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical-stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms, and CoImmune,…

Read More
Merck to Acquire Maryland-based OncoImmune’s Promising COVID-19 Drug in $425 Million Deal · BioBuzz

Merck to Acquire Maryland-based OncoImmune’s Promising COVID-19 Drug in $425 Million Deal · BioBuzz

KENILWORTH, N.J., & ROCKVILLE, Md.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United States and Canada, and OncoImmune, a privately-held, clinical-stage biopharmaceutical company,…

Read More
NORTHPOND VENTURES: Harvard’s Wyss Institute Creates Research And Innovation Alliance With Northpond Labs | Business Wire

NORTHPOND VENTURES: Harvard’s Wyss Institute Creates Research And Innovation Alliance With Northpond Labs | Business Wire

BOSTON--(BUSINESS WIRE)--Harvard University's Wyss Institute for Biologically Inspired Engineering has established its first research and innovation alliance by joining forces with Northpond Labs, the…

Read More
TIME Names Johns Hopkins’ COVID Dashboard A Top Invention Of 2020 – CBS Baltimore

TIME Names Johns Hopkins’ COVID Dashboard A Top Invention Of 2020 – CBS Baltimore

BALTIMORE (WJZ) — TIME Magazine has named the Johns Hopkins University’s COVID-19 dashboard a top invention of 2020. The Johns Hopkins Coronavirus Resource Center…

Read More